Demography, patterns of care and survival outcomes in patients with malignant tumors of trachea: A systematic review and individual patient data analysis of 733 patients
Malignant tumor of the trachea (MTT) is a rare disease [1,2] comprising around 0.01-0.4% of all cancer cases. In the US, incidence of these tumors is less than 0.2 per 1, 00,000 population [3,4]. Frequently, these tumors are diagnosed late as they present with non-specific symptoms and are often mis-diagnosed as asthma or other respiratory disorder. A wide range of histological subtypes has been described in the literature adding to the heterogeneity of presentation, treatment and outcome of these tumors.
Source: Lung Cancer - Category: Cancer & Oncology Authors: Supriya Mallick, Rony Benson, Prashanth Giridhar, Angel Rajan Singh, Goura K Rath Source Type: research
More News: Asthma | Cancer | Cancer & Oncology | Lung Cancer | Rare Diseases | Respiratory Medicine | Tracheal Cancer